Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Migraine without Aura

• Responding With Evidence and Access for Childhood Headaches
• Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab
• Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab
• Effect of Riocigaut on Migraine Attack Induction and Cerebral Vasodilation in Migraine Patients.
• A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
• The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.
• TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
• Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
• A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
• Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
• Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
• Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
• A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
• Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
• Ibuprofen in Migraine Patients
• The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
• A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
• 1H Magnetic Resonance Spectroscopy in Migraine Patients
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
• PACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine
• A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
• Can DFN-15 Terminate Migraine With Allodynia?
• PACAP27 Headache Properties in Migraine Without Aura Patients
• ACT Therapy for HF Migraine
• The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
• Pharmacologically Triggered Migraine Without Aura and Neuroimaging
• Understanding the Pathophysiology of Migraine Pain
• Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
• The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
• PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load
• CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load
• Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
• Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
• The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
• Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
• Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance
• Preventive Treatment of Episodic and Chronic Migraine
• Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
• Candesartan Versus Propranolol for Migraine Prevention
• A Study of a Melatonin Receptor Agonist to Prevent Migraine
• Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
• Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
• PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
• Functional MRI (fMRI) in CGRP Induced Migraine
• Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
• Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
• Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
• Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
• A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
• A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
• A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
• Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
• Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
• Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache